Skip to main content
Premium Trial:

Request an Annual Quote

Atlas Certification to Enable Development of MDx-related Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atlas Biolabs today said that it has achieved DIN EN ISO 13485:2003 + AC:2009 standard, allowing the company to develop a software-based expert system for assessing chromosomal aberrations.

The system will complement Atlas' genotyping and molecular karyotyping services.

According to the company, the certification is a milestone for Atlas and compliance is necessary to develop and distribute software that falls within the scope of the European directive 98/79/EC for in vitro diagnostics.

"The new certificate gives the company a stronger position in molecular diagnostics and makes it an ideal partner for other companies that are looking to develop or have developed in vitro diagnostic tools," Atlas said in a statement.

The company had been certified according to DIN EN ISO 9001 since 2008.

Based in Berlin, Atlas provides genomics services, such as microarray-based genomic services, targeted sequence capture, and next-generation sequencing analysis.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.